Post-approval studies (Phase 4)Ended earlyNCT02618109
What this trial is testing
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
Who this might be right for
B Acute Lymphoblastic LeukemiaLeukemia Relapse
University Hospital, Angers 119